| Product NDC: | 55566-0302 | 
| Proprietary Name: | ACTHREL | 
| Non Proprietary Name: | corticorelin ovine triflutate | 
| Active Ingredient(s): | 100 ug/2mL & nbsp; corticorelin ovine triflutate | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55566-0302 | 
| Labeler Name: | Ferring Pharmaceuticals Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020162 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19960523 | 
| Package NDC: | 55566-0302-1 | 
| Package Description: | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) | 
| NDC Code | 55566-0302-1 | 
| Proprietary Name | ACTHREL | 
| Package Description | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) | 
| Product NDC | 55566-0302 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | corticorelin ovine triflutate | 
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 19960523 | 
| Marketing Category Name | NDA | 
| Labeler Name | Ferring Pharmaceuticals Inc. | 
| Substance Name | CORTICORELIN OVINE TRIFLUTATE | 
| Strength Number | 100 | 
| Strength Unit | ug/2mL | 
| Pharmaceutical Classes |